Insmed

FDA starts review of first bronchiectasis drug candidate
Pharmaphorum
Fri, 02/7/25 - 11:03 am
FDA
Insmed
brensocatib
bronchiectasis
Insmed’s shares double as lung disease med powers past expectations in phase 3
Fierce Biotech
Tue, 05/28/24 - 10:57 am
Insmed
bronchiectasis
clinical trials
brensocatib
Insmed’s brensocatib: A candidate for bronchiectasis treatment, closer to approval
Clinical Trials Arena
Wed, 05/8/24 - 11:12 am
Insmed
brensocatib
bronchiectasis
clinical trials
Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals
Xconomy
Mon, 02/3/20 - 11:56 pm
Insmed
clinical trials
non-cystic fibrosis bronchiectasis
INS1007
The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference
Motley Fool
Fri, 01/11/19 - 09:59 am
Loxo Oncology
SAGE Therapeutics
Insmed
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
Yahoo/Benzinga
Sun, 08/5/18 - 07:25 pm
biotech
IPOs
Pain Therapeutics
Remoxy
Vertex Pharmaceuticals
lumacaftor/ivacaftor
Alnylam
Patisiran
Regeneron
Eylea
Insmed
Paratek
Vaccinex
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
Motley Fool
Sat, 09/9/17 - 02:55 pm
biotech
Insmed
NewLink Genetics
Voyager Therapeutics
ALIS
indoximod/Keytruda
VY-AADC01
Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch
Endpoints
Tue, 09/5/17 - 10:16 pm
Insmed
clinical trials
Arikayce
ALIS
AstraZeneca licenses respiratory drug to Insmed
Yahoo/Reuters
Wed, 10/5/16 - 09:35 am
AstraZeneca
Insmed
AZD7986
Respiratory
Insmed reports 2Q loss
Yahoo/AP
Thu, 08/6/15 - 10:22 am
Insmed
earnings
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
Fri, 06/20/14 - 12:31 pm
antibiotic resistance
antibiotics
Cubist Pharmaceuticals
Durata
Insmed
Medicines Company
Tetraphase Pharmaceuticals
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tue, 04/8/14 - 09:46 am
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals
Insmed's lung infection drug fails mid-stage study
Yahoo/Reuters
Wed, 03/26/14 - 08:03 am
Insmed
Arikace
nontuberculous mycobacterial lung infections
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wed, 01/22/14 - 08:41 am
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study
TheStreet.com
Tue, 10/22/13 - 08:30 am
Insmed
Arikace
cystic fibrosis
New Patents for Insmed's Arikace
Yahoo/Zacks
Tue, 09/17/13 - 09:50 am
patents
Insmed
Arikace
Our BioPharma Catalyst Watch List
Seeking Alpha
Thu, 08/15/13 - 12:09 pm
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals

Pages